Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice

Mise à jour : Il y a 4 ans
Référence : NCT01454024

Femme et Homme

  • | Pays :
  • Pakistan
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This study is conducted in Asia. The aim of of this study is to evaluate the safety of NovoPen® 3 and/or FlexPen® devices (if available on the market) measured by the number of adverse events and technical complaints in patients with type 1 and type 2 diabetes in routine clinical practice.


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 1 ,Diabetes Mellitus, Type 2 ,Delivery Systems

Liens